Cocrystallization of Dolutegravir Sodium via Liquid-Assisted Grinding: Preparation, Characterization, and Ex vivo Evaluation
Ars Pharmaceutica (Internet) · 20.03.2026 · 67 (2) · 154-166
DOI: 10.30827/ars.v67i2.34754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ars Pharmaceutica (Internet), online erschienen am 20.03.2026. Verfasst von Rajendra Mogal und 1 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction: Dolutegravir sodium is a second-line antiretroviral drug recommended by the World Health Organization for the treatment of people living with human immunodeficiency virus (HIV) who have failed a first-line regimen. It exhibits poor aqueous solubility and classified as Class II drug as per Biopharmaceutics Classification System. Additionally, it has low oral bioavailability (
Zitieren
APA
Mogal, R., & Patil, M. (2026). Cocrystallization of Dolutegravir Sodium via Liquid-Assisted Grinding: Preparation, Characterization, and Ex vivo Evaluation. Ars Pharmaceutica (Internet), 67(2), 154-166. https://doi.org/10.30827/ars.v67i2.34754
Vancouver
Mogal R, Patil M. Cocrystallization of Dolutegravir Sodium via Liquid-Assisted Grinding: Preparation, Characterization, and Ex vivo Evaluation. Ars Pharmaceutica (Internet). 2026;67(2):154-166. doi:10.30827/ars.v67i2.34754
BibTeX
@article{Mogal2026,
author = {Mogal, Rajendra and Patil, Moreshwar},
title = {Cocrystallization of Dolutegravir Sodium via Liquid-Assisted Grinding: Preparation, Characterization, and Ex vivo Evaluation},
journal = {Ars Pharmaceutica (Internet)},
year = {2026},
volume = {67},
number = {2},
pages = {154--166},
doi = {10.30827/ars.v67i2.34754}
}
EUVIMED